Journey II BCS EU Observational Trial

NCT02211794 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 175

Last updated 2024-01-31

No results posted yet for this study

Summary

Post-market study to confirm the safety and efficacy of the Journey II BCS knee prosthesis.

Conditions

  • Degenerative Joint Disease

Interventions

OTHER

data collection

Sponsors & Collaborators

  • Smith & Nephew Orthopaedics AG

    lead INDUSTRY

Principal Investigators

  • Mike Risebury, MD · North Hampshire Hospital

  • Fabio Catani, Prof · University of Modena and Reggio Emilia

  • Jan Victor, Prof · UZ Ghent

  • Gijs Van Hellemondt · Sint-Maartenskliniek Nijmegen

  • Stig Heir · Martina Hansens Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • Belgium
  • Italy
  • Netherlands
  • Norway
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02211794 on ClinicalTrials.gov